Asset Dedication LLC’s BioLineRX BLRX Stock Holding History

Asset Dedication LLC’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	-$1K	–	756
2020 Q2	$1K	Hold	9	–	–	﹤0.01%	608
2020 Q1	$0	Hold	9	–	–	﹤0.01%	660
2019 Q4	$1K	Hold	9	–	–	﹤0.01%	695
2019 Q3	$1K	Buy	+9	New	+$1.25K	﹤0.01%	578

Other funds holding BLRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Asset Dedication LLC's BLRX Position: Q3 2020 in Review

Asset Dedication LLC sold out of BioLineRX (BLRX) in Q3 2020, closing a stake of 9 shares — an estimated $1K sold.

Asset Dedication LLC first reported a position in BLRX in Q3 2019 and held it in 4 quarters. The position peaked at $1K in Q2 2020. 18 funds tracked by Wall St. Rank hold BLRX as of Q3 2020.

Asset Dedication LLC reported no remaining BioLineRX position as of Q3 2020 after selling out during the quarter.
Asset Dedication LLC sold 9 BioLineRX shares in Q3 2020, an estimated $1K.
Asset Dedication LLC first reported a position in BioLineRX in Q3 2019 and held it in 4 quarters.
Asset Dedication LLC's BioLineRX position peaked at $1K in Q2 2020.
18 funds tracked by Wall St. Rank held BioLineRX as of Q3 2020.

Based on Asset Dedication LLC's 13F filing for Q3 2020, filed 20 Oct 2020.